Phluence
Phluence is a private B2B SaaS company that provides an agentic AI platform automating post-prescription patient services workflows for pharmaceutical manufacturers, including benefits investigation, prior authorization, affordability programs, and gross-to-net optimization, serving enterprise customers such as GSK, AstraZeneca, Biogen, Arcutis Biotherapeutics, and Braeburn.
- Company typePrivate
- Founded2015
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Phluence does
Phluence is a private B2B SaaS company that provides an agentic AI platform for pharmaceutical commercialization, headquartered in San Francisco with 11–50 employees. The company's core offering automates post-prescription patient services workflows for pharmaceutical manufacturers—including benefits investigation, prior authorization, affordability program enrollment, specialty pharmacy fulfillment, field reimbursement management, and gross-to-net optimization—replacing traditional FTE-heavy hub models with always-on software agents. The platform is organized around three integrated layers: an Action Agents library (a catalog of pre-built specialized agents such as Eligibility, Alternate Coverage, Pharmacy, Bridge Conversion, and Benefit Sentinel), an Access Agent that applies tokenization-based temporal intelligence to longitudinal patient data, and a Longitudinal Data layer that integrates electronic health records, pharmacy claims, and patient registries to build per-patient journey views.
The company serves named enterprise pharmaceutical customers including GSK, AstraZeneca, Biogen, Arcutis Biotherapeutics, and Braeburn, selling through direct enterprise field sales with proof-of-concept and ROI-based engagement. Phluence reports quantifiable outcomes including a 10% higher first-fill rate and 18% more time on therapy for patients interacting with its digital assistants versus non-users. The platform is HIPAA, GDPR, UK GDPR, and CCPA compliant, with self-certified alignment to the EU-U.S. Data Privacy Framework. A separate Patient Engagement Platform module and a set of revenue-conversion modules (Bridge Conversion, Benefit Sentinel, Annual Reverification/Reenrollment) extend coverage across the full post-prescription journey.
Phluence has raised approximately $15.75M in disclosed equity funding across rounds from 2017 through 2022, led historically by DigiTx Partners and Primera Capital. In November 2025, Precision AQ made a strategic investment that establishes Precision AQ as a parent entity; Jake Graetz holds dual roles as Phluence CEO and Precision AQ EVP for Strategy, Innovation & Partnerships. The company has no public revenue disclosure, operates primarily in the United States, and distributes its platform through direct enterprise sales with no publicly disclosed pricing or tiered plans.
Phluence firmographics
Firmographics- Name
- Phluence
- Legal name
- Phluence, Inc.
- Website
- https://phluence.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Phluence is a private B2B SaaS company that provides an agentic AI platform automating post-prescription patient services workflows for pharmaceutical manufacturers, including benefits investigation, prior authorization, affordability programs, and gross-to-net optimization, serving enterprise customers such as GSK, AstraZeneca, Biogen, Arcutis Biotherapeutics, and Braeburn.
- Ownership category
- akta.pro rank
Phluence industry classification
Industry- Product category
- Pharmaceutical Commercialization Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
- akta.pro secondary industries
- EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD), Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)
Keywords
Where Phluence is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Phluence business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Platform Licensing/SaaS: Phluence provides an AI-powered workflow platform to pharmaceutical manufacturers on a subscription or licensing basis. The platform is described as a tech-first system that excels at managing complex workflows 24/7 without increasing human footprint of manufacturer operations.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Phluence product offering
Product offeringCore offering
Phluence provides an agentic AI-powered workflow platform for pharmaceutical commercialization. The platform combines Action Agents (autonomous AI agents), Access Agent (temporal intelligence for patient-level insights), and Longitudinal Data (patient history from EHRs, pharmacy claims, and registries) to automate patient services operations including benefits verification, prior authorization, enrollment, affordability program eligibility, pharmacy fulfillment, and adherence monitoring. It is sold as a SaaS subscription to pharmaceutical manufacturers for patient engagement, intelligent workflow automation, and revenue optimization.
Product overview
Phluence is an agentic AI-powered workflow platform for pharmaceutical commercialization. The platform consists of a core Phluence Platform built on three integrated layers: Action Agents (a library of pre-built and custom AI agents), Access Agent (temporal intelligence for patient-level insights), and Longitudinal Data (patient data from multiple sources). The platform assembles solutions across three categories: Patient Engagement Solutions (Patient Marketing Agent, Enrollment Agent, Call Center/Contact Center Agent, Consented Patient Pipeline), Intelligent Workflow (Patient Case Management Agent, FRM Automation Agent, HCP Workflow Agent, Market Access Insight Agent), and Revenue Conversion Solutions (Bridge Conversion Agent, Benefit Sentinel, Gross-to-Net Optimization Agent). Phluence also offers a dedicated Patient Engagement Platform covering the full post-prescription journey from brand awareness through care continuity.
Differentiator
Problem solved
Functional benefit
Products and services
- Phluence Platform A data-driven, dynamic healthcare AI platform integrating Action Agents, Access Agent, and Longitudinal Data to execute patient services functions for pharmaceutical manufacturers. Manages complex workflows 24/7 without increasing the human footprint of a manufacturer's patient services operation.
- Patient Engagement Solutions Suite of AI-driven solutions including Patient Marketing Agent, Enrollment Agent, Call Center/Contact Center Agent, and Consented Patient Pipeline for automating patient outreach, enrollment, and ongoing support. Enables proactive engagement via in-EHR and Digital Ad pipeline with Conversational and Voice Assistance.
- Intelligent Workflow Solutions Multiagent workflow automation including Patient Case Management, FRM Automation, HCP Workflow, and Market Access Insight agents for field reimbursement teams, healthcare providers, and patient support teams.
- Revenue Conversion Solutions Solutions including Bridge Conversion, Benefit Sentinel, and Gross-to-Net (GTN) Optimization to prevent revenue leakage, monitor patient benefit carve-outs, address accumulator and maximizer impact, claw back duplicative 340B rebates, and transition patients from temporary bridge programs to permanent coverage.
- Patient Engagement Platform Multi-stage platform guiding patients through the post-prescription journey covering brand offer awareness, benefits investigation, virtual hub enrollment, prior authorization, affordability programs, pharmacy fulfillment, and care continuity.
Quantifiable outcome
- 10% higher first-fill rate for patients who interacted with digital assistant vs non-users
- +1 more outcomes
Companies that use Phluence
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles1 record
Phluence technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
Phluence partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights6 records
Phluence competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva provides cloud software for the life sciences industry, including commercial and patient engagement capabilities. It is the dominant horizontal pharma cloud platform that Phluence must compete against or integrate with for pharma manufacturer accounts.
- AssistRx: AssistRx delivers specialty therapy patient access and hub services for pharmaceutical manufacturers, including electronic benefits investigation, prior authorization, and patient enrollment — directly overlapping with Phluence's Patient Engagement and Workflow solutions.
- OptimizeRx: OptimizeRx provides a digital therapeutics activation platform that engages patients and providers at the point of prescription. Its patient engagement and adherence use cases closely parallel Phluence's Patient Marketing and Enrollment Agents.
- Inmar Intelligence: Inmar operates hub services, Alternate Funding Program management, and 340B-related workflows for pharma manufacturers — directly overlapping with Phluence's Benefit Sentinel, AFP, and GTN Optimization modules.
- Sonexus Health: Sonexus Health (part of BPL) provides patient access, hub, and pharmacy services for specialty pharmaceutical manufacturers. It is a direct competitor in the virtualized patient services and bridge conversion space that Phluence targets.
Broad incumbents
- IQVIA: IQVIA is a large CRO and commercialization services provider with patient engagement, market access, and hub services offerings. It overlaps with Phluence's patient services and market access solutions but as part of a much broader portfolio.
- Medidata (Dassault Systèmes): Medidata offers clinical and commercial platforms for life sciences, including patient engagement capabilities. It is a broader incumbent that intersects with Phluence's market access and patient journey solutions.
Others
- ZS Associates: ZS is a major consulting and technology firm serving pharmaceutical commercialization, including patient services and market access strategy. It is an adjacent enabler that often partners with or competes against platforms like Phluence.
- Deloitte (Pharma & Life Sciences practice): Deloitte's pharma and life sciences practice delivers patient services, market access, and commercialization consulting — an adjacent service provider that competes for the same enterprise budget as Phluence.
Emerging players
- PatientPoint: PatientPoint provides digital patient engagement at the point of care, with overlap to Phluence's patient engagement and adherence use cases but a narrower channel focus (in-office touchpoints).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Phluence social profiles
Digital presencePhluence compliance and trust
Trust signalCompliance4 records
Phluence financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phluence leadership team
Management profileNumber of profiles
Profiles17 records
Phluence funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phluence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phluence
What does Phluence do?
Phluence provides an agentic AI-powered workflow platform for pharmaceutical commercialization. The platform combines Action Agents (autonomous AI agents), Access Agent (temporal intelligence for patient-level insights), and Longitudinal Data (patient history from EHRs, pharmacy claims, and registries) to automate patient services operations including benefits verification, prior authorization, enrollment, affordability program eligibility, pharmacy fulfillment, and adherence monitoring. It is sold as a SaaS subscription to pharmaceutical manufacturers for patient engagement, intelligent workflow automation, and revenue optimization.
Is Phluence a public or private company?
Phluence is a private company. It is classified as corporate owned and is currently operating.
When was Phluence founded?
Phluence was founded in 2015. It employs 11 to 50 people.
Where is Phluence based?
Phluence is headquartered in San Francisco, United States, in the North America region.
How does Phluence make money?
One revenue line is on record: platform Licensing/SaaS.
Who are Phluence's main competitors?
Direct peers on record are Veeva Systems, AssistRx, OptimizeRx, Inmar Intelligence and Sonexus Health. Broad incumbents are IQVIA and Medidata (Dassault Systèmes). Others are ZS Associates and Deloitte (Pharma & Life Sciences practice). PatientPoint is listed as an emerging player.
Does Phluence have an API?
No public API is recorded for Phluence.
What industry is Phluence in?
Phluence's product category is Pharmaceutical Commercialization Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLALAKAD, EHR/EMR Integration & Interoperability Middleware (HL7/FHIR). Its NAICS code is 513210 and its SIC code is 7372.